Aquaporin A/S

As of June 30, 2025, Aquaporin A/S has 23.26M shares outstanding.

These figures are as of June 30, 2025. The price-to-sales ratio is 5.07, and the price-to-book ratio stands at 1.56.

These figures are as of June 30, 2025. The EV/Sales ratio of 6.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of June 30, 2025, Aquaporin A/S maintains a current ratio of 3.28, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.15, indicating elevated leverage, while an interest coverage ratio of -6.31 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2025, Aquaporin A/S posted a negative return on equity (ROE) of -104.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -63.60, reflecting losses generated across the asset base. Inventory turnover of 2.50 indicates how many times Aquaporin A/S sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on February 3, 2026, Aquaporin A/S's stock has declined approximately 97.07% over the past 52 weeks. The 50-day moving average sits at 2.01, while the 200-day moving average is 7.62.

Over the twelve months ended June 30, 2025, Aquaporin A/S posted a gross margin of 45.24, reflecting its pricing power and cost economics. The operating margin of -289.30 and net profit margin of -319.11 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2025. Free cash flow yield is negative at -41.87: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -51.60, meaning Aquaporin A/S raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Aquaporin A/S's most recent stock split took place on April 8, 2024 with a 41:63 split ratio.

As of June 30, 2025, Aquaporin A/S has an Altman Z-Score of 1.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.